Condition: Non-segmental Vitiligo · Sponsor: Vyne Therapeutics Inc.
The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of VYN201 Gel in subjects with non-segmental vitiligo.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Cahaba Dermatology & Skin Health Center | Birmingham, Alabama, United States | — |
| Saguaro Dermatology | Phoenix, Arizona, United States | — |
| Center for Dermatology and Plastic Surgery/CCT Research | Scottsdale, Arizona, United States | — |
| Noble Clinical Research | Tucson, Arizona, United States | — |
| Clinical Trial Institute of Northwest Arkansas, LLC | Fayetteville, Arkansas, United States | — |
| Burke Pharmaceutical Research | Hot Springs, Arkansas, United States | — |
| California Dermatology & Clinical Research Institute | Encinitas, California, United States | — |
| First OC Dermatology Research, Inc | Fountain Valley, California, United States | — |
| Center for Dermatology Clinical Research, Inc | Fremont, California, United States | — |
| Marvel Clinical Research | Huntington Beach, California, United States | — |
| Northridge Clinical Trials | Northridge, California, United States | — |
| Palmtree Clinical Research, Inc. | Palm Springs, California, United States | — |
+ 37 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06493578